Skip to content

Clinical Performance Evaluation of Sansure Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing)

Clinical Performance Evaluation of Sansure Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) - REQA_24005_SNSR_HBV

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00034136
Enrollment
144
Registered
2024-07-24
Start date
2024-07-22
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis B is an inflammation of the liver caused by the HBV virus. It is easily transmitted, especially during sex and through contaminated syringes and accessories. The infection can become chronic, i.e. make you permanently ill

Interventions

Group 1: Test device: Hepatitis B Virus DNA Quantitative Fluorescence Diagnostic Kit (PCR-Fluorescence Probing) This is a cross-sectional, observational design study with retrospective/leftover blood

Sponsors

Sansure Biotech Inc.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -HBV negative Specificity: -HBV Antigen positive/ negative Interference: HBV negative Proben with -Hepatitis A virus (HAV) positive -Human Immunodeficiency Virus (HIV) positive -Hepatitis C virus (HCV) positive -Influenza A virus (IAV) positive -Human Cytomegalovirus (CMV) positive -Candida albicans positive -Epstein-Barr virus (EBV) positive -Treponema pallidum positive -Herpes simplex virus 2 (HHV-2) positive -Staphylococcus aureus positive

Exclusion criteria

Exclusion criteria: -Sample was not frozen -Tube was damaged -No blinding ID

Design outcomes

Primary

MeasureTime frame
diagnostic specificity (DSpec) represented by negative percentage agreement, NPA) Diagnostic Specificity=NPA=B2/((B1+B2)=TN/((FP+TN) ))

Secondary

MeasureTime frame
crossreactivity tested against genomes of: -Hepatitis A virus (HAV) -Human Immunodeficiency Virus (HIV) -Hepatitis C virus (HCV) -Influenza A virus (IAV) -Human Cytomegalovirus (CMV) -Candida albicans -Epstein-Barr virus (EBV) -Treponema pallidum -Herpes simplex virus 2 (HHV-2) -Staphylococcus aureus interference tested in: - Women who have had more than one pregnancy - Rheumatoid factor positive samples - anti- E. coli antibodies - anti-Candida albicans antibodies

Countries

Germany

Contacts

Public ContactHakan Inan

Requalite GmbH

info@requalite.com+49 89 32800304

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026